Airway diseases
Interstitial lung diseases
Symposium
Emerging imaging biomarkers in lung disease
Translational
Clinical
Aims : To present information on imaging methods including positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI) and micro-CT; to present translational human and animal studies that have identified novel imaging biomarkers for assessment of fibrosis and inflammation.
Target audience :
Clinical researcher, Medical Student, Pathologist, Patient, Radiologist, Scientist (basic, translational)
Methods :
Cell and molecular biology, Imaging, Physiology
14:45
Introduction
1
3988
14:50
Emerging diagnostics from MRI, PET and CT studies of lung disease
J. Eaden(Sheffield (South Yorkshire), United Kingdom)
COI
-
Description
2
3989
15:05
Preclinical models and imaging biomarkers of lung injury and disease
I. Mahmutovic Persson(Lund, Sweden)
COI
-
Description
3
3990
15:20
Micro-computed tomography to quantify lung fibrosis in vivo
G. Vande Velde(Leuven, Belgium)
COI
-
Description
4
3991
15:35
Novel imaging biomarkers for assessment of lung fibrosis and inflammation
J. Jacob(London, United Kingdom)
COI
-
Description
5
3992
15:50
Discussion and Q&A
6
3993
. . .
